Neuroblastic tumors associated with opsoclonus-myoclonus syndrome: histological, immunohistochemical and molecular features of 15 Italian cases

Detection of specific sequences among DNA fragments separated by gel electrophoresis

1975 • 33,059 citations

Statistical Methods for Rates and Proportions

2003 • 17,930 citations

Cytogenetic analysis using quantitative, high-sensitivity, fluorescence hybridization.

1986 • 3,231 citations

A Report of Three Cases

1986 • 1,193 citations

The Use of Antiavidin Antibody and Avidin-Biotin-Peroxidase Complex in Immunoperoxidase Technics

1981 • 1,067 citations

The International Neuroblastoma Pathology Classification (the Shimada system)

1999 • 966 citations

International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma.

1988 • 593 citations

Terminology and morphologic criteria of neuroblastic tumors: recommendations by the International Neuroblastoma Pathology Committee.

1999 • 565 citations

Terminology and morphologic criteria of neuroblastic tumors

1999 • 538 citations

Application of DNA flow cytometry to paraffin‐embedded archival material for the study of aneuploidy and its clinical significance

1985 • 416 citations

Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients.

1984 • 364 citations

Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells.

1985 • 317 citations

Onconeural antigens and the paraneoplastic neurologic disorders: at the intersection of cancer, immunity, and the brain.

1996 • 273 citations

Myoclonic encephalopathy of infants

1962 • 270 citations

A microdissection technique for archival DNA analysis of specific cell populations in lesions < 1 mm in size.

1995 • 267 citations

Opsoclonus‐myoclonus‐ataxia syndrome in neuroblastoma: Clinical outcome and antineuronal antibodies—a report from the children's cancer group study

2001 • 233 citations

Favorable prognosis for survival in children with coincident opso-myoclonus and neuroblastoma

1976 • 191 citations

Expression of GD2 ganglioside by untreated primary human neuroblastomas.

1986 • 190 citations

Long-term neurologic outcome in children with opsoclonus-myoclonus associated with neuroblastoma: A report from the Pediatric Oncology Group

1997 • 176 citations

Opsoclonus, Myoclonus, Ataxia, and Encephalopathy in Adults with Cancer

1988 • 150 citations

Antineuronal Antibodies in Patients With Neuroblastoma and Paraneoplastic Opsoclonus-Myoclonus

2000 • 147 citations

Major histocompatibility proteins, anti-Hu antibodies, and paraneoplastic encephalomyelitis in neuroblastoma and small cell lung cancer

1995 • 144 citations

Neural cell adhesion molecule (NCAM) is the antigen recognized by monoclonal antibodies of similar specificity in small‐cell lung carcinoma and neuroblastoma

1989 • 133 citations

MYCN oncogene amplification in neuroblastoma is associated with worse prognosis, except in stage 4s: the Italian experience with 295 children.

1997 • 109 citations

Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma

1994 • 108 citations

Opsoclonus‐myoclonus‐ataxia syndrome in neuroblastoma: Histopathologic features–A report from the children's cancer group†

2001 • 107 citations

Opsoclonus-Ataxia Due to Childhood Neural Crest Tumors: A Chronic Neurologic Syndrome

1990 • 76 citations

Localized but unresectable neuroblastoma: treatment and outcome of 145 cases. Italian Cooperative Group for Neuroblastoma.

1993 • 69 citations

Molecular detection of GAGE expression in peripheral blood and bone marrow: utility as a tumor marker for neuroblastoma.

1997 • 69 citations

Syndrome of opsoclonus‐myoclons caused by coxsackie B3 infection

1983 • 66 citations

Neurological sequelae of the dancing eye syndrome

1996 • 65 citations

Clinical outcome in children with acute cerebellar encephalopathy and neuroblastoma

1989 • 59 citations

Detection of microscopic neuroblastoma in marrow by histology, immunocytology, and reverse transcription-PCR of multiple molecular markers.

1998 • 57 citations

Myoclonic encephalopathy of infants or "dancing eyes syndrome". Report of 7 cases with long-term follow-up and review of the literature (cases with and without neuroblastoma).

1979 • 54 citations

Expression of MAGE-1, MAGE-3 and MART-1 genes in neuroblastoma

1996 • 54 citations

Effect of steroid and high-dose immunoglobulin therapy on opsoclonus-myoclonus syndrome occurring in neuroblastoma

1998 • 52 citations

Neuroblastoma-associated opsoclonus-myoclonus treated with intravenously administered immune globulin G

1995 • 51 citations

Single copies of the N-myc oncogene in neuroblastomas from children presenting with the syndrome of opsoclonus-myoclonus

1988 • 43 citations

Gas chromatographic determination of urinary vanilglycolic acid, vanilglycol, vanilacetic acid and vanillactic acid — Chemical parameters for the diagnosis of neurogenic tumours and the evaluation of their treatment

1976 • 40 citations

Paraneoplastic syndromes

1997 • 39 citations

Encephalopathia Myoclonica Infantilis (Kinsbourne) and Neuroblastoma in Children. A Report of Three Cases

1974 • 39 citations

MAGE-1 andMAGE-3 or-6 expression in neuroblastoma-related pediatric solid tumors

1996 • 36 citations

Autoimmunity to ion-channels and other proteins in paraneoplastic disorders

1996 • 34 citations

High‐dose iv human immunoglobulin in a case with infantile opsoclonus polymyoclonia syndrome

1992 • 33 citations

Opsomyoclonus and Neuroblastoma

1979 • 33 citations

Poor outcome in patients with advanced stage neuroblastoma and coincident opsomyoclonus syndrome

1994 • 32 citations

Opsoclonus-Myoclonus Syndrome as a Paraneoplastic Manifestation of Renal Cell Carcinoma

2002 • 26 citations

Opsoclonus/myoclonus: Paraneoplastic syndrome of neuroblastoma

1996 • 10 citations